Cover Image
市場調查報告書

電氣生理學設備:醫療設備的開發平台評估

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 350912
出版日期 內容資訊 英文 272 Pages
訂單完成後即時交付
價格
Back to Top
電氣生理學設備:醫療設備的開發平台評估 Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年05月01日 內容資訊: 英文 272 Pages
簡介

本報告提供全球電氣生理學設備的市場上主要的開發中產品 (醫療設備)與其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 電氣生理學設備市場概要

第3章 電氣生理學設備市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規途徑別
  • 開發中產品:估計認證時期別
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 電氣生理學設備的企業:各臨床實驗階段的開發中產品
  • 電氣生理學設備:各臨床實驗階段的開發中產品

第5章 電氣生理學設備市場:企業·產品概要

  • AblaCor Medical Corporation
    • 開發中產品及進行中的臨床實驗概要
  • Acutus Medical, Inc.
  • Advanced Cardiac Therapeutics, Inc.
  • AFfix Medical Ltd.
  • Apama Medical, Inc.
  • AtriCure, Inc.
  • Baylor College of Medicine
  • Biosense Webster, Inc.
  • BioSig Technologies, Inc.
  • BioTex, Inc.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardima, Inc. (Inactive)
  • CardioFocus, Inc.
  • CardioNova Ltd.
  • CathEffects LLC
  • CathRx Ltd
  • Cordis Corporation
  • CoRepair, Inc
  • CyberHeart Incorporated
  • Epicardial Technologies Inc
  • FocusStart Orthosensors
  • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
  • Hansen Medical, Inc.
  • Imricor Medical Systems, Inc.
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Mayo Clinic
  • MC10, Inc.
  • Medicalgorithmics S.A.
  • Medispec LTD
  • Medlumics S.L.
  • Medtronic plc
  • MedWaves Incorporated
  • MicroPort Scientific
  • MRI Interventions, Inc
  • nContact, Inc.
  • North Carolina State University
  • Northwestern University
  • Philips Healthcare
  • SCR, Inc.
  • St. Jude Medical, Inc.
  • Stereotaxis, Inc.
  • Strategic Polymer Sciences, Inc
  • The Cleveland Clinic Foundation
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vimecon GmbH
  • Vivonics, Inc.
  • Voyage Medical

第6章 電氣生理學設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0539EPD

GlobalData's Medical Devices sector report, "Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Electrophysiology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Electrophysiology Devices Overview 15

3 Products under Development 17

  • 3.1 Electrophysiology Devices - Pipeline Products by Stage of Development 17
  • 3.2 Electrophysiology Devices - Pipeline Products by Segment 18
  • 3.3 Electrophysiology Devices - Pipeline Products by Territory 19
  • 3.4 Electrophysiology Devices - Pipeline Products by Regulatory Path 20
  • 3.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date 21
  • 3.6 Electrophysiology Devices - Ongoing Clinical Trials 22

4 Electrophysiology Devices - Pipeline Products under Development by Companies 23

  • 4.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development 23
  • 4.2 Electrophysiology Devices - Pipeline Products by Stage of Development 26

5 Electrophysiology Devices Companies and Product Overview 29

  • 5.1 Ablacon Inc Company Overview 29
    • 5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.2 Advanced Cardiac Therapeutics, Inc. Company Overview 30
    • 5.2.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.3 Apama Medical, Inc. Company Overview 33
    • 5.3.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.4 AtriCure Inc Company Overview 34
    • 5.4.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.5 Aust Development, LLC Company Overview 35
    • 5.5.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.6 Baylor College of Medicine Company Overview 36
    • 5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.7 Ben-Gurion University of the Negev Company Overview 37
    • 5.7.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.8 Berlin Heals GmbH Company Overview 38
    • 5.8.1 Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.9 Biosense Webster Inc Company Overview 39
    • 5.9.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.10 BioSig Technologies Inc Company Overview 45
    • 5.10.1 BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.11 BioTex Inc Company Overview 47
    • 5.11.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.12 Boston Scientific Corp Company Overview 49
    • 5.12.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.13 Cardima, Inc. (Inactive) Company Overview 58
    • 5.13.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.14 CardioFocus Inc Company Overview 60
    • 5.14.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.15 CardioNova Ltd Company Overview 65
    • 5.15.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.16 CathEffects LLC Company Overview 66
    • 5.16.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.17 CathRx Ltd Company Overview 67
    • 5.17.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.18 CathVision Aps Company Overview 73
    • 5.18.1 CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.19 Cibiem Inc Company Overview 74
    • 5.19.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.20 Columbia University Company Overview 77
    • 5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.21 Cordis Corp Company Overview 78
    • 5.21.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.22 CoRepair, Inc Company Overview 80
    • 5.22.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.23 CryoTherapeutics Gmbh Company Overview 81
    • 5.23.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.24 CyberHeart Inc Company Overview 82
    • 5.24.1 CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.25 EP Dynamics, Inc. Company Overview 85
    • 5.25.1 EP Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.26 EP Solutions SA Company Overview 88
    • 5.26.1 EP Solutions SA Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.27 EPD Solutions Ltd Company Overview 89
    • 5.27.1 EPD Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.28 Epicardial Technologies Inc (Inactive) Company Overview 90
    • 5.28.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 90
  • 5.29 FocusStart LLC Company Overview 91
    • 5.29.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.30 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 92
    • 5.30.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.31 Genetesis LLC Company Overview 93
    • 5.31.1 Genetesis LLC Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.32 Hansen Medical Inc Company Overview 97
    • 5.32.1 Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.33 Imricor Medical Systems Inc Company Overview 100
    • 5.33.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 100
  • 5.34 Interventional Imaging, Inc. Company Overview 101
    • 5.34.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
  • 5.35 Iowa Approach Inc. Company Overview 102
    • 5.35.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
  • 5.36 Johns Hopkins University Company Overview 104
    • 5.36.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 104
  • 5.37 King's College London Company Overview 105
    • 5.37.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 105
  • 5.38 Maestro Heart SA Company Overview 106
    • 5.38.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 106
  • 5.39 Mayo Clinic Company Overview 107
    • 5.39.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 107
  • 5.40 MC10 Inc Company Overview 108
    • 5.40.1 MC10 Inc Pipeline Products & Ongoing Clinical Trials Overview 108
  • 5.41 Medlumics SL Company Overview 109
    • 5.41.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 109
  • 5.42 Medtronic plc Company Overview 110
    • 5.42.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 110
  • 5.43 MedWaves Inc Company Overview 115
    • 5.43.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 115
  • 5.44 MicroPort Scientific Corp Company Overview 116
    • 5.44.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 116
  • 5.45 MRI Interventions Inc Company Overview 120
    • 5.45.1 MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 120
  • 5.46 North Carolina State University Company Overview 121
    • 5.46.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 121
  • 5.47 Northwestern University Company Overview 122
    • 5.47.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 122
  • 5.48 Philips Healthcare Company Overview 123
    • 5.48.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 123
  • 5.49 SCR, Inc. Company Overview 124
    • 5.49.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
  • 5.50 Seattle Children's Hospital Company Overview 125
    • 5.50.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 125
  • 5.51 Sotera Medical Corp Company Overview 126
    • 5.51.1 Sotera Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 126
  • 5.52 St. Jude Medical LLC Company Overview 127
    • 5.52.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 127
  • 5.53 Stereotaxis Inc Company Overview 129
    • 5.53.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 129
  • 5.54 Strategic Polymer Sciences, Inc Company Overview 130
    • 5.54.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 130
  • 5.55 University of Maryland Company Overview 131
    • 5.55.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 131
  • 5.56 University of Michigan Company Overview 132
    • 5.56.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 132
  • 5.57 University of Rochester Company Overview 133
    • 5.57.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 133
  • 5.58 University of Texas Medical Branch at Galveston Company Overview 134
    • 5.58.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 134
  • 5.59 Vanderbilt University Company Overview 135
    • 5.59.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 135
  • 5.60 Vimecon GmbH Company Overview 136
    • 5.60.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 136
  • 5.61 Viscardia Inc Company Overview 139
    • 5.61.1 Viscardia Inc Pipeline Products & Ongoing Clinical Trials Overview 139
  • 5.62 Vivonics, Inc. Company Overview 140
    • 5.62.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
  • 5.63 Voyage Medical (Inactive) Company Overview 141
    • 5.63.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141

6 Electrophysiology Devices- Recent Developments 142

  • 6.1 Apr 13, 2018: LKC Technologies Partners with US Retina in GPO Program 142
  • 6.2 Apr 11, 2018: Stereotaxis Announces Expanded European Labeling for Navigation in the Pericardial Space 142
  • 6.3 Apr 09, 2018: Fischer Medical Receives U.S. FDA 510(k) Clearance to Market Bloom2 Cardiac Stimulator 143
  • 6.4 Apr 06, 2018: BioSig Technologies to Present at the MicroCap Conference 143
  • 6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 143
  • 6.6 Mar 29, 2018: MicroPort EP Attends the 10th VAS-CHINA 144
  • 6.7 Mar 28, 2018: BioSig Announces Submission of FDA 510(k) Application for PURE EP System 145
  • 6.8 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 145
  • 6.9 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 147
  • 6.10 Mar 19, 2018: Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation 148
  • 6.11 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales 149
  • 6.12 Mar 15, 2018: ADANI will exhibit medical X-ray equipment at CMEF 2018 152
  • 6.13 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 152
  • 6.14 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 153
  • 6.15 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 154
  • 6.16 Feb 27, 2018: Ogden Regional Medical Center Earns Echocardiography Accreditation 154
  • 6.17 Feb 26, 2018: CardioFocus Announces Initiation of HeartLight X3 Clinical Evaluation 155
  • 6.18 Feb 26, 2018: EPD Obtains European Regulatory Approval for Its Cardiac Mapping and Navigation System 156
  • 6.19 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 156
  • 6.20 Feb 23, 2018: Atrial fibrillation patients benefit most from this treatment 157
  • 6.21 Feb 22, 2018: BioSig Technologies to Partner with Focus Marketing 158
  • 6.22 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 159
  • 6.23 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 160
  • 6.24 Feb 21, 2018: ADANI will exhibit its solutions at ECR 2018 161
  • 6.25 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 161
  • 6.26 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 162
  • 6.27 Feb 19, 2018: Experimentica Names Dr. Marc Cerrada-Gimenez As new Director For In Vivo Pharmacology 163
  • 6.28 Feb 14, 2018: Uscom: Appendix 4D Results and Update 163
  • 6.29 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 164
  • 6.30 Feb 08, 2018: MicroPort EP Attends 2018 Dunhuang Cardiovascular Disease Forum to Display Columbus 165
  • 6.31 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology 166
  • 6.32 Feb 07, 2018: Soren Friis Appointed Director of Global Customer Relations at Nanion 166
  • 6.33 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017 167
  • 6.34 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 168
  • 6.35 Jan 31, 2018: First Triojection Cases in Germany were Recently Completed by Prof. Dr. Thomas Vogl MD 170
  • 6.36 Jan 31, 2018: Allegheny Health Network Neurosurgeons First in Region to Provide New Treatment for Painful Spinal Tumors 170
  • 6.37 Jan 31, 2018: Uscom: Appendix 4C Results and Update Quarter ended 31 December 2017 171
  • 6.38 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 172
  • 6.39 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 172
  • 6.40 Jan 29, 2018: ADANI Participates In Arab Health Exhibition 2018 173
  • 6.41 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move 173
  • 6.42 Jan 09, 2018: Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations 173
  • 6.43 Jan 09, 2018: MicroPort Selected as "2017 China Innovative Medical Device Company" 174
  • 6.44 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation 174
  • 6.45 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 175
  • 6.46 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 175
  • 6.47 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 176
  • 6.48 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 176
  • 6.49 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 177

7 Appendix 269

  • 7.1 Methodology 269
  • 7.2 About GlobalData 272
  • 7.3 Contact Us 272
  • 7.4 Disclaimer 272

List of Tables

1.1 List of Tables

  • Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development 17
  • Table 2: Electrophysiology Devices - Pipeline Products by Segment 18
  • Table 3: Electrophysiology Devices - Pipeline Products by Territory 19
  • Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 20
  • Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 21
  • Table 6: Electrophysiology Devices - Ongoing Clinical Trials 22
  • Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development 23
  • Table 8: Electrophysiology Devices - Pipeline Products by Stage of Development 26
  • Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 10: Ablasense - Product Status 29
  • Table 11: Ablasense - Product Description 29
  • Table 12: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 13: ACT Cardiac Ablation Catheter - Product Status 30
  • Table 14: ACT Cardiac Ablation Catheter - Product Description 30
  • Table 15: Advanced Cardiac Therapeutics, Inc. - Ongoing Clinical Trials Overview 31
  • Table 16: ACT Cardiac Ablation Catheter - A Randomized Controlled Clinical Evaluation of the DiamondTemp System for the Treatment of Paroxysmal Atrial Fibrillation 32
  • Table 17: ACT Cardiac Ablation Catheter - Advanced Cardiac Therapeutics DiamondTemp Temperature-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 32
  • Table 18: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 19: Apama Ablation Catheter - Product Status 33
  • Table 20: Apama Ablation Catheter - Product Description 33
  • Table 21: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 22: Next Generation RF Generator - Product Status 34
  • Table 23: Next Generation RF Generator - Product Description 34
  • Table 24: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 25: Endovascular Cardiac Optical Mapping Device - Product Status 35
  • Table 26: Endovascular Cardiac Optical Mapping Device - Product Description 35
  • Table 27: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 28: Catheter-Based Electrophysiological Imaging System - Product Status 36
  • Table 29: Catheter-Based Electrophysiological Imaging System - Product Description 36
  • Table 30: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 31: Excitation Wave Cancellation Device - Product Status 37
  • Table 32: Excitation Wave Cancellation Device - Product Description 37
  • Table 33: Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 34: Berlin Heals Cardiac Microcurrent Therapy Device - Product Status 38
  • Table 35: Berlin Heals Cardiac Microcurrent Therapy Device - Product Description 38
  • Table 36: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 37: Balloon Catheter - Atrial Fibrillation - Product Status 39
  • Table 38: Balloon Catheter - Atrial Fibrillation - Product Description 39
  • Table 39: CARTO 4 - Product Status 40
  • Table 40: CARTO 4 - Product Description 40
  • Table 41: CARTO SMARTTOUCH 5D Catheter - Product Status 40
  • Table 42: CARTO SMARTTOUCH 5D Catheter - Product Description 40
  • Table 43: Next Generation Ablation Catheter - Product Status 41
  • Table 44: Next Generation Ablation Catheter - Product Description 41
  • Table 45: nMARQ Pulmonary Vein Isolation System - Product Status 41
  • Table 46: nMARQ Pulmonary Vein Isolation System - Product Description 42
  • Table 47: Biosense Webster Inc - Ongoing Clinical Trials Overview 43
  • Table 48: nMARQ Pulmonary Vein Isolation System - Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation 44
  • Table 49: BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 50: PURE EP System - Product Status 45
  • Table 51: PURE EP System - Product Description 45
  • Table 52: PURE EP Version 2.0 - Product Status 46
  • Table 53: PURE EP Version 2.0 - Product Description 46
  • Table 54: PURE EP Version 3.0 - Product Status 46
  • Table 55: PURE EP Version 3.0 - Product Description 46
  • Table 56: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 57: Cooled Tip Catheter - Product Status 47
  • Table 58: Cooled Tip Catheter - Product Description 47
  • Table 59: Water-cooled Catheter - Product Status 48
  • Table 60: Water-cooled Catheter - Product Description 48
  • Table 61: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 62: Cryo Balloon Catheter - Product Status 49
  • Table 63: Cryo Balloon Catheter - Product Description 49
  • Table 64: DirectSense Rx Catheter - Product Status 50
  • Table 65: DirectSense Rx Catheter - Product Description 50
  • Table 66: Force Sensing Afib Catheter - Product Status 50
  • Table 67: Force Sensing Afib Catheter - Product Description 50
  • Table 68: IntellaNav MiFi OI AF Ablation Catheter - Product Status 51
  • Table 69: IntellaNav MiFi OI AF Ablation Catheter - Product Description 51
  • Table 70: LabSystem PRO NextGen - Product Status 51
  • Table 71: LabSystem PRO NextGen - Product Description 52
  • Table 72: Lesion Assessment Device - Product Status 52
  • Table 73: Lesion Assessment Device - Product Description 52
  • Table 74: Next Generation Blazer Catheter - Product Status 52
  • Table 75: Next Generation Blazer Catheter - Product Description 53
  • Table 76: Next Generation IntellaTip Catheter - Product Status 53
  • Table 77: Next Generation IntellaTip Catheter - Product Description 53
  • Table 78: OI System - Product Status 53
  • Table 79: OI System - Product Description 54
  • Table 80: Boston Scientific Corp - Ongoing Clinical Trials Overview 55
  • Table 81: Next Generation IntellaTip Catheter - Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 56
  • Table 82: IntellaNav MiFi OI AF Ablation Catheter - Electrical Coupling Information from the Rhythmia HDx Mapping System and Direct Sense Technology in the Treatment of Paroxysmal Atrial Fibrillation - A Non-randomized, Prospective Study 57
  • Table 83: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 84: CADENCE EPL - Product Status 58
  • Table 85: CADENCE EPL - Product Description 58
  • Table 86: EP Ablation System - Product Status 58
  • Table 87: EP Ablation System - Product Description 59
  • Table 88: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 89: HeartLight Excalibur Balloon - Product Status 60
  • Table 90: HeartLight Excalibur Balloon - Product Description 60
  • Table 91: HeartLight X3 System - Product Status 61
  • Table 92: HeartLight X3 System - Product Description 61
  • Table 93: CardioFocus Inc - Ongoing Clinical Trials Overview 62
  • Table 94: HeartLight Excalibur Balloon - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation 63
  • Table 95: HeartLight X3 System - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation 64
  • Table 96: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 97: Electrophysiology Catheter - Atrial Fibrillation - Product Status 65
  • Table 98: Electrophysiology Catheter - Atrial Fibrillation - Product Description 65
  • Table 99: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 100: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 66
  • Table 101: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 66
  • Table 102: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 103: CathRx 4mm Therapeutic Catheter - Product Status 67
  • Table 104: CathRx 4mm Therapeutic Catheter - Product Description 67
  • Table 105: CathRx 8mm Therapeutic Catheter - Product Status 68
  • Table 106: CathRx 8mm Therapeutic Catheter - Product Description 68
  • Table 107: Khelix Fixed Catheter - Product Status 68
  • Table 108: Khelix Fixed Catheter - Product Description 69
  • Table 109: Khelix Fixed Loop EP Catheter - Product Status 69
  • Table 110: Khelix Fixed Loop EP Catheter - Product Description 69
  • Table 111: Khelix Fixed Loop Steerable EP Catheter - Product Status 69
  • Table 112: Khelix Fixed Loop Steerable EP Catheter - Product Description 70
  • Table 113: Khelix Irrigated Ablation EP Catheter - Product Status 70
  • Table 114: Khelix Irrigated Ablation EP Catheter - Product Description 70
  • Table 115: Khelix Non-Irrigated Ablation EP Catheter - Product Status 71
  • Table 116: Khelix Non-Irrigated Ablation EP Catheter - Product Description 71
  • Table 117: Khelix Steerable Catheter - Product Status 71
  • Table 118: Khelix Steerable Catheter - Product Description 72
  • Table 119: Khelix Variable Loop Steerable EP Catheter - Product Status 72
  • Table 120: Khelix Variable Loop Steerable EP Catheter - Product Description 72
  • Table 121: CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 122: CathVision Cube - Product Status 73
  • Table 123: CathVision Cube - Product Description 73
  • Table 124: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 125: Catheter-Based Carotid Body Ablation System - Product Status 74
  • Table 126: Catheter-Based Carotid Body Ablation System - Product Description 74
  • Table 127: Cibiem Inc - Ongoing Clinical Trials Overview 75
  • Table 128: Catheter-Based Carotid Body Ablation System - First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study 76
  • Table 129: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 130: Optically-Integrated RFA Catheter - Product Status 77
  • Table 131: Optically-Integrated RFA Catheter - Product Description 77
  • Table 132: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 133: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 78
  • Table 134: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 78
  • Table 135: EP Lesion Assessment Device - Product Status 79
  • Table 136: EP Lesion Assessment Device - Product Description 79
  • Table 137: CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 138: Radiofrequency Device - Product Status 80
  • Table 139: Radiofrequency Device - Product Description 80
  • Table 140: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 141: Cryotherapy System - Coronary Artery Disease - Product Status 81
  • Table 142: Cryotherapy System - Coronary Artery Disease - Product Description 81
  • Table 143: CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 144: CyberHeart System - Product Status 82
  • Table 145: CyberHeart System - Product Description 82
  • Table 146: CyberHeart Inc - Ongoing Clinical Trials Overview 83
  • Table 147: CyberHeart System - CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients with Refractory Ventricular Tachycardia 84
  • Table 148: EP Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 149: EPD D700 System - Product Status 85
  • Table 150: EPD D700 System - Product Description 85
  • Table 151: EP Dynamics, Inc. - Ongoing Clinical Trials Overview 86
  • Table 152: EPD D700 System - Dielectric Unravelling of Radiofrequency Ablation Effectiveness: Durable-I Study 87
  • Table 153: EP Solutions SA Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 154: Second Generation AMYCARD System - Product Status 88

List of Figures

1.2 List of Figures

  • Figure 1: Electrophysiology Devices - Pipeline Products by Stage of Development 17
  • Figure 2: Electrophysiology Devices - Pipeline Products by Segment 18
  • Figure 3: Electrophysiology Devices - Pipeline Products by Territory 19
  • Figure 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 20
  • Figure 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Electrophysiology Devices - Ongoing Clinical Trials 22
Back to Top